Advances in inflammatory bowel disease.
Optimal management of patients with IBD requires a multidisciplinary approach involving primary care physicians, gastroenterologists, surgeons, radiologists, and nutritionists. The rapidly evolving medical armamentarium promises better quality of life for patients afflicted with these complex, chronic diseases. It is expected that future development of biologic agents will add to the therapeutic options, although it may complicate treatment algorithms. Surgical advancements, particularly in ileoanal anastomosis and bowel preservation by strictureplasty, have improved outcome dramatically. The focus on development of new therapies and refinement of older ones demands a constant attention to the latest peer-reviewed literature and that the clinician keep abreast of the various advancements that have been summarized here.
Stotland
B R
BR
Department of Medicine, Boston Medical Center, Boston University Medical School, Massachusetts, USA.
Stein
R B
RB
Lichtenstein
G R
GR
D000465:Algorithms; D000714:Anastomosis, Surgical; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005194:Family Practice; D005762:Gastroenterology; D013502:General Surgery; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D009747:Nutritional Physiological Phenomena; D010348:Patient Care Team; D017712:Peer Review, Research; D016737:Proctocolectomy, Restorative; D011788:Quality of Life; D011871:Radiology; D016896:Treatment Outcome